TU‐E‐BRB‐01: Surface Based Distance Measures with Treatment Technique Specific Gradient Factor for IMRT QA Tolerances Determination

Heng Li, L. Dong, L. Zhang, J. N. Yang, M. T. Gillin, R. Mohan, X. R. Zhu

Research output: Contribution to journalArticle

Abstract

Purpose: To investigate surface based distance measurement method with prior knowledge of dose gradient for dose comparison and IMRT QA. Method and Materials: A dose distribution can be viewed as a surface in the hyper‐space. The generalized distance between two dose surfaces can be calculated by introducing a dose gradient factor α, which is defined as the multiplicative inverse of the average gradient of a dose distribution. Ten regular IMRT and 5 spine IMRT SRS patient plans were studied to determine the average dose gradient factors for these two applications. Spatial and dose shifts were applied to 10 regular cases, distance and γ ‐ index between the original and shifted distributions were calculated. The distance between plans and measurements were then calculated for all test cases. The distribution of distance was analyzed and patient statistics were evaluated, and 90 percentile (D90) results were used to determine the pass criteria for γ ‐ index method. Results: The mean of dose gradient factors for 10 regular plans and 5 SRS plans are 1.031 mm/% and 0.337 mm/%, respectively. 48% of the shifted distributions that satisfy γ <1 with 3mm and 3% criteria in 90% pixels have a true distance > 3mm. The 95% confidence interval (CI) of D90 was [2.43, 3.73] mm for regular cases, and [0.80, 1.42] mm for SRS cases. The DTA and DD limits for γ ‐ index were determined to be 3.73 mm and 3.73% for regular IMRT, and 1.42 mm and 4.73% for SRS respectively. Conclusion: Distance and dose gradient information can be used to quantify the difference between two dose distributions and determine the tolerance for a specific treatment delivery technique. The current use of γ index underestimates the difference between two dose distributions. Tolerance values should be determined for different applications based on patient statistics and population studies.

Original languageEnglish (US)
Number of pages1
JournalMedical physics
Volume37
Issue number6
DOIs
StatePublished - Jan 1 2010
Externally publishedYes

Fingerprint

Population Characteristics
Spine
Therapeutics
Confidence Intervals

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

TU‐E‐BRB‐01 : Surface Based Distance Measures with Treatment Technique Specific Gradient Factor for IMRT QA Tolerances Determination. / Li, Heng; Dong, L.; Zhang, L.; Yang, J. N.; Gillin, M. T.; Mohan, R.; Zhu, X. R.

In: Medical physics, Vol. 37, No. 6, 01.01.2010.

Research output: Contribution to journalArticle

Li, Heng ; Dong, L. ; Zhang, L. ; Yang, J. N. ; Gillin, M. T. ; Mohan, R. ; Zhu, X. R. / TU‐E‐BRB‐01 : Surface Based Distance Measures with Treatment Technique Specific Gradient Factor for IMRT QA Tolerances Determination. In: Medical physics. 2010 ; Vol. 37, No. 6.
@article{10564ab740aa4cdfaea5305272352941,
title = "TU‐E‐BRB‐01: Surface Based Distance Measures with Treatment Technique Specific Gradient Factor for IMRT QA Tolerances Determination",
abstract = "Purpose: To investigate surface based distance measurement method with prior knowledge of dose gradient for dose comparison and IMRT QA. Method and Materials: A dose distribution can be viewed as a surface in the hyper‐space. The generalized distance between two dose surfaces can be calculated by introducing a dose gradient factor α, which is defined as the multiplicative inverse of the average gradient of a dose distribution. Ten regular IMRT and 5 spine IMRT SRS patient plans were studied to determine the average dose gradient factors for these two applications. Spatial and dose shifts were applied to 10 regular cases, distance and γ ‐ index between the original and shifted distributions were calculated. The distance between plans and measurements were then calculated for all test cases. The distribution of distance was analyzed and patient statistics were evaluated, and 90 percentile (D90) results were used to determine the pass criteria for γ ‐ index method. Results: The mean of dose gradient factors for 10 regular plans and 5 SRS plans are 1.031 mm/{\%} and 0.337 mm/{\%}, respectively. 48{\%} of the shifted distributions that satisfy γ <1 with 3mm and 3{\%} criteria in 90{\%} pixels have a true distance > 3mm. The 95{\%} confidence interval (CI) of D90 was [2.43, 3.73] mm for regular cases, and [0.80, 1.42] mm for SRS cases. The DTA and DD limits for γ ‐ index were determined to be 3.73 mm and 3.73{\%} for regular IMRT, and 1.42 mm and 4.73{\%} for SRS respectively. Conclusion: Distance and dose gradient information can be used to quantify the difference between two dose distributions and determine the tolerance for a specific treatment delivery technique. The current use of γ index underestimates the difference between two dose distributions. Tolerance values should be determined for different applications based on patient statistics and population studies.",
author = "Heng Li and L. Dong and L. Zhang and Yang, {J. N.} and Gillin, {M. T.} and R. Mohan and Zhu, {X. R.}",
year = "2010",
month = "1",
day = "1",
doi = "10.1118/1.3469284",
language = "English (US)",
volume = "37",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - TU‐E‐BRB‐01

T2 - Surface Based Distance Measures with Treatment Technique Specific Gradient Factor for IMRT QA Tolerances Determination

AU - Li, Heng

AU - Dong, L.

AU - Zhang, L.

AU - Yang, J. N.

AU - Gillin, M. T.

AU - Mohan, R.

AU - Zhu, X. R.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Purpose: To investigate surface based distance measurement method with prior knowledge of dose gradient for dose comparison and IMRT QA. Method and Materials: A dose distribution can be viewed as a surface in the hyper‐space. The generalized distance between two dose surfaces can be calculated by introducing a dose gradient factor α, which is defined as the multiplicative inverse of the average gradient of a dose distribution. Ten regular IMRT and 5 spine IMRT SRS patient plans were studied to determine the average dose gradient factors for these two applications. Spatial and dose shifts were applied to 10 regular cases, distance and γ ‐ index between the original and shifted distributions were calculated. The distance between plans and measurements were then calculated for all test cases. The distribution of distance was analyzed and patient statistics were evaluated, and 90 percentile (D90) results were used to determine the pass criteria for γ ‐ index method. Results: The mean of dose gradient factors for 10 regular plans and 5 SRS plans are 1.031 mm/% and 0.337 mm/%, respectively. 48% of the shifted distributions that satisfy γ <1 with 3mm and 3% criteria in 90% pixels have a true distance > 3mm. The 95% confidence interval (CI) of D90 was [2.43, 3.73] mm for regular cases, and [0.80, 1.42] mm for SRS cases. The DTA and DD limits for γ ‐ index were determined to be 3.73 mm and 3.73% for regular IMRT, and 1.42 mm and 4.73% for SRS respectively. Conclusion: Distance and dose gradient information can be used to quantify the difference between two dose distributions and determine the tolerance for a specific treatment delivery technique. The current use of γ index underestimates the difference between two dose distributions. Tolerance values should be determined for different applications based on patient statistics and population studies.

AB - Purpose: To investigate surface based distance measurement method with prior knowledge of dose gradient for dose comparison and IMRT QA. Method and Materials: A dose distribution can be viewed as a surface in the hyper‐space. The generalized distance between two dose surfaces can be calculated by introducing a dose gradient factor α, which is defined as the multiplicative inverse of the average gradient of a dose distribution. Ten regular IMRT and 5 spine IMRT SRS patient plans were studied to determine the average dose gradient factors for these two applications. Spatial and dose shifts were applied to 10 regular cases, distance and γ ‐ index between the original and shifted distributions were calculated. The distance between plans and measurements were then calculated for all test cases. The distribution of distance was analyzed and patient statistics were evaluated, and 90 percentile (D90) results were used to determine the pass criteria for γ ‐ index method. Results: The mean of dose gradient factors for 10 regular plans and 5 SRS plans are 1.031 mm/% and 0.337 mm/%, respectively. 48% of the shifted distributions that satisfy γ <1 with 3mm and 3% criteria in 90% pixels have a true distance > 3mm. The 95% confidence interval (CI) of D90 was [2.43, 3.73] mm for regular cases, and [0.80, 1.42] mm for SRS cases. The DTA and DD limits for γ ‐ index were determined to be 3.73 mm and 3.73% for regular IMRT, and 1.42 mm and 4.73% for SRS respectively. Conclusion: Distance and dose gradient information can be used to quantify the difference between two dose distributions and determine the tolerance for a specific treatment delivery technique. The current use of γ index underestimates the difference between two dose distributions. Tolerance values should be determined for different applications based on patient statistics and population studies.

UR - http://www.scopus.com/inward/record.url?scp=82755187403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82755187403&partnerID=8YFLogxK

U2 - 10.1118/1.3469284

DO - 10.1118/1.3469284

M3 - Article

AN - SCOPUS:82755187403

VL - 37

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -